Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA

Jodi L Pawluski1, Ursula M Brain, Caroline M Underhill

  • 1Early Human Experience Unit, Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada. j.pawluski@maastrichtuniversity.nl

Psychoneuroendocrinology
|December 20, 2011
PubMed

Insights

Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants altered neonatal corticosteroid-binding globulin (CBG) levels. In SSRI-exposed infants, higher neonatal CBG predicted a smaller diurnal cortisol change, impacting the developing hypothalamic-pituitary-adrenal (HPA) system.

Area of Science:

  • Neuroendocrinology
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Serotonin plays a crucial role in the development of the hypothalamic-pituitary-adrenal (HPA) axis.
  • Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants may disrupt HPA axis development and function.
  • Investigating the impact of SSRIs on neonatal and infant cortisol and corticosteroid-binding globulin (CBG) is essential.

Purpose of the Study:

  • To examine the relationship between prenatal SSRI exposure, maternal mood, and neonatal/infant cortisol and CBG levels.
  • To assess the long-term implications of altered CBG levels in infants exposed to SSRIs prenatally.

Main Methods:

  • Assayed serum cortisol and CBG in mothers and neonates at delivery.
  • Documented maternal mood symptoms during gestation.
  • Measured infant salivary cortisol levels at 3 months of age.

Main Results:

  • Prenatal SSRI exposure increased neonatal serum CBG levels, irrespective of maternal depression.
  • Neonatal serum cortisol levels were not affected by SSRI exposure or maternal mood.
  • Higher neonatal CBG in SSRI-exposed infants predicted a reduced diurnal cortisol change at 3 months.

Conclusions:

  • Prenatal SSRI exposure influences the developing HPA system by altering neonatal CBG and infant cortisol diurnal patterns.
  • Further research is needed on the long-term functional consequences of prenatal SSRI exposure on CBG gene expression and HPA system development.
Abstract

Related Concept Videos

Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
Stella Chess...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...